These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30554913)

  • 1. From Discovery to Bedside: Targeting the Ubiquitin System.
    Wertz IE; Wang X
    Cell Chem Biol; 2019 Feb; 26(2):156-177. PubMed ID: 30554913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site.
    Paiva SL; da Silva SR; de Araujo ED; Gunning PT
    J Med Chem; 2018 Jan; 61(2):405-421. PubMed ID: 28076680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
    Akinjiyan FA; Carbonneau S; Ross NT
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.
    de Bie P; Ciechanover A
    Cell Death Differ; 2011 Sep; 18(9):1393-402. PubMed ID: 21372847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin--the kiss of death goes Nobel. Will you be quitting?
    Behuliak M; Celec P; Gardlik R; Palffy R
    Bratisl Lek Listy; 2005; 106(3):93-100. PubMed ID: 16026142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of allostery in the ubiquitin-proteasome system.
    Liu J; Nussinov R
    Crit Rev Biochem Mol Biol; 2013; 48(2):89-97. PubMed ID: 23234564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.
    Armstrong SR; Wu H; Wang B; Abuetabh Y; Sergi C; Leng RP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation.
    Chen G; Huang H; Fröhlich O; Yang Y; Klein JD; Price SR; Sands JM
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1528-34. PubMed ID: 18784257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assays of Mdm2 ubiquitin ligase activity and other ubiquitin-utilizing enzymes for inhibitor discovery.
    Auger KR; Copeland RA; Lai Z
    Methods Enzymol; 2005; 399():701-17. PubMed ID: 16338390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survey on the Expression of the Ubiquitin Proteasome System Components HECT- and RBR-E3 Ubiquitin Ligases and E2 Ubiquitin-Conjugating and E1 Ubiquitin-Activating Enzymes during Human Brain Development.
    Magnati S; Alladio E; Bracco E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes.
    David Y; Ternette N; Edelmann MJ; Ziv T; Gayer B; Sertchook R; Dadon Y; Kessler BM; Navon A
    J Biol Chem; 2011 Dec; 286(51):44104-44115. PubMed ID: 21965653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orchestra for assembly and fate of polyubiquitin chains.
    Kuhlbrodt K; Mouysset J; Hoppe T
    Essays Biochem; 2005; 41():1-14. PubMed ID: 16250894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International Conference.
    Skaug B; Chen ZJ
    IDrugs; 2010 Apr; 13(4):224-7. PubMed ID: 20373248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro autoubiquitination activity of E3 ubiquitin ligases of the N-degron pathway.
    Sandmann A; Dissmeyer N
    Methods Enzymol; 2023; 686():205-220. PubMed ID: 37532400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting substrates to cullin 4-dependent ubiquitin ligases by DDB1.
    McCall CM; Hu J; Xiong Y
    Cell Cycle; 2005 Jan; 4(1):27-9. PubMed ID: 15655366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The components and functions of the ubiquitin-proteasome pathway].
    Ni XG; Zhao P
    Sheng Li Ke Xue Jin Zhan; 2006 Jul; 37(3):255-8. PubMed ID: 17009738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.